These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 32853649)

  • 1. Phosphoproteomic analysis identifies phospho-Threonine-17 site of phospholamban important in low molecular weight isoform of fibroblast growth factor 2-induced protection against post-ischemic cardiac dysfunction.
    Manning JR; Wijeratne AB; Oloizia BB; Zhang Y; Greis KD; Schultz JEJ
    J Mol Cell Cardiol; 2020 Nov; 148():1-14. PubMed ID: 32853649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low molecular weight fibroblast growth factor-2 signals via protein kinase C and myofibrillar proteins to protect against postischemic cardiac dysfunction.
    Manning JR; Perkins SO; Sinclair EA; Gao X; Zhang Y; Newman G; Pyle WG; Schultz Jel J
    Am J Physiol Heart Circ Physiol; 2013 May; 304(10):H1382-96. PubMed ID: 23479264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of FGF2 high molecular weight (HMW) isoforms in the development of cardiac ischemia-reperfusion injury.
    Liao S; Bodmer JR; Azhar M; Newman G; Coffin JD; Doetschman T; Schultz Jel J
    J Mol Cell Cardiol; 2010 Jun; 48(6):1245-54. PubMed ID: 20116383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cardioprotective effect of the low molecular weight isoform of fibroblast growth factor-2: the role of JNK signaling.
    Liao S; Porter D; Scott A; Newman G; Doetschman T; Schultz Jel J
    J Mol Cell Cardiol; 2007 Jan; 42(1):106-20. PubMed ID: 17150229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of Protein Kinase Novel 1 (PKN1) is associated with mild systolic and diastolic contractile dysfunction, increased phospholamban Thr17 phosphorylation, and exacerbated ischaemia-reperfusion injury.
    Francois AA; Obasanjo-Blackshire K; Clark JE; Boguslavskyi A; Holt MR; Parker PJ; Marber MS; Heads RJ
    Cardiovasc Res; 2018 Jan; 114(1):138-157. PubMed ID: 29045568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative phosphoproteomics using acetone-based peptide labeling: method evaluation and application to a cardiac ischemia/reperfusion model.
    Wijeratne AB; Manning JR; Schultz Jel J; Greis KD
    J Proteome Res; 2013 Oct; 12(10):4268-79. PubMed ID: 24016359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The protein kinase C pathway mediates cardioprotection induced by cardiac-specific overexpression of fibroblast growth factor-2.
    House SL; Melhorn SJ; Newman G; Doetschman T; Schultz Jel J
    Am J Physiol Heart Circ Physiol; 2007 Jul; 293(1):H354-65. PubMed ID: 17337596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of dual-site phospholamban phosphorylation in the stunned heart: insights from phospholamban site-specific mutants.
    Said M; Vittone L; Mundina-Weilenmann C; Ferrero P; Kranias EG; Mattiazzi A
    Am J Physiol Heart Circ Physiol; 2003 Sep; 285(3):H1198-205. PubMed ID: 12763747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Status of Ca2+/calmodulin protein kinase phosphorylation of cardiac SR proteins in ischemia-reperfusion.
    Netticadan T; Temsah R; Osada M; Dhalla NS
    Am J Physiol; 1999 Sep; 277(3):C384-91. PubMed ID: 10484325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium/calmodulin-dependent protein kinase II mediates cardioprotection of intermittent hypoxia against ischemic-reperfusion-induced cardiac dysfunction.
    Yu Z; Wang ZH; Yang HT
    Am J Physiol Heart Circ Physiol; 2009 Aug; 297(2):H735-42. PubMed ID: 19525372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of phospholamban in ischemia-reperfusion injury: functional role of Thr17 residue.
    Mattiazzi A; Mundiña-Weilenmann C; Vittone L; Said M
    Mol Cell Biochem; 2004 Aug; 263(1-2):131-6. PubMed ID: 15524173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of dual-site phospholamban phosphorylation in intermittent hypoxia-induced cardioprotection against ischemia-reperfusion injury.
    Xie Y; Zhu Y; Zhu WZ; Chen L; Zhou ZN; Yuan WJ; Yang HT
    Am J Physiol Heart Circ Physiol; 2005 Jun; 288(6):H2594-602. PubMed ID: 15637115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced phosphorylation of phospholamban and downregulation of sarco/endoplasmic reticulum Ca2+ ATPase type 2 (SERCA 2) in cardiac sarcoplasmic reticulum from rabbits with heart failure.
    Currie S; Smith GL
    Cardiovasc Res; 1999 Jan; 41(1):135-46. PubMed ID: 10325961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholamban phosphorylation in ischemia-reperfused heart. Effect of pacing during ischemia and response to a beta-adrenergic challenge.
    Mundiña-Weilenmann C; Said M; Vittone L; Ferrero P; Mattiazzi A
    Mol Cell Biochem; 2003 Oct; 252(1-2):239-46. PubMed ID: 14577598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac-specific overexpression of fibroblast growth factor-2 protects against myocardial dysfunction and infarction in a murine model of low-flow ischemia.
    House SL; Bolte C; Zhou M; Doetschman T; Klevitsky R; Newman G; Schultz Jel J
    Circulation; 2003 Dec; 108(25):3140-8. PubMed ID: 14656920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin inhibits beta-adrenergic action in ischemic/reperfused heart: a novel mechanism of insulin in cardioprotection.
    Yu QJ; Si R; Zhou N; Zhang HF; Guo WY; Wang HC; Gao F
    Apoptosis; 2008 Feb; 13(2):305-17. PubMed ID: 18165901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted inhibition of sarcoplasmic reticulum CaMKII activity results in alterations of Ca2+ homeostasis and cardiac contractility.
    Ji Y; Zhao W; Li B; Desantiago J; Picht E; Kaetzel MA; Schultz Jel J; Kranias EG; Bers DM; Dedman JR
    Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H599-606. PubMed ID: 16143658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decoy peptides targeted to protein phosphatase 1 inhibit dephosphorylation of phospholamban in cardiomyocytes.
    Oh JG; Kim J; Jang SP; Nguen M; Yang DK; Jeong D; Park ZY; Park SG; Hajjar RJ; Park WJ
    J Mol Cell Cardiol; 2013 Mar; 56():63-71. PubMed ID: 23262438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed phospholamban phosphorylation in post-conditioned heart favours Ca2+ normalization and contributes to protection.
    Inserte J; Hernando V; Ruiz-Meana M; Poncelas-Nozal M; Fernández C; Agulló L; Sartorio C; Vilardosa U; Garcia-Dorado D
    Cardiovasc Res; 2014 Sep; 103(4):542-53. PubMed ID: 25020913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ablation of phospholamban rescues reperfusion arrhythmias but exacerbates myocardium infarction in hearts with Ca2+/calmodulin kinase II constitutive phosphorylation of ryanodine receptors.
    Valverde CA; Mazzocchi G; Di Carlo MN; Ciocci Pardo A; Salas N; Ragone MI; Felice JI; Cely-Ortiz A; Consolini AE; Portiansky E; Mosca S; Kranias EG; Wehrens XHT; Mattiazzi A
    Cardiovasc Res; 2019 Mar; 115(3):556-569. PubMed ID: 30169578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.